Cristina Setim Freitas

Biologist specialized in Pharmacology with broad-based background in pharmacological research, drug development, and innovation. Solid knowledge in genotoxicity based (GLP studies), on scientific methodologies and governing regulations (ANVISA, FDA, ICH and OCDE). Study Director of in vitro and in vivo efficacy area (proof of concept non-GLP studies), and coordinates the Genotoxicity Sector (coordinate, supervise and manage GLP studies of the Genotoxicity Battery), at CIENP.